Zydus, supported by Gates Foundation, to develop combination vaccine against shigellosis and typhoid Read more
Zydus Lifesciences partners with Zhuhai Beihai Biotech for BEIZRAY commercialisation in the US Read more
Nadda urges industry, academia collaboration to build better healthcare at Healthcare Summit at IIMA Read more
Zydus receives USFDA approval to conduct Phase II(b) clinical trial for Usnoflast, a novel oral NLRP3 inflammasome inhibitor in patients with ALS Read more